Extensive Decay in Primary Molars Clinical Trial
Official title:
Comparison of The Success Rates of Four Different Pulpotomy Techniques
| Verified date | April 2017 |
| Source | Istanbul University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This randomized clinical trial was conducted to examine and compare the effectiveness of pulpotomy in primary molars treated with calcium silicate based materials including Biodentine and two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®). Ferric sulfate pulpotomy was selected to represent the control group. 116 primary molars in 29 children were treated by pulpotomy and followed for a period of 24 months.
| Status | Completed |
| Enrollment | 38 |
| Est. completion date | February 15, 2016 |
| Est. primary completion date | January 15, 2014 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 5 Years to 7 Years |
| Eligibility |
Inclusion Criteria: - Patients were eligible if they were 5 to 7 years old, healthy and cooperative, and had at least four carious primary molars, each of which was in a different quadrant and required a pulpotomy. The criteria for the selection of the teeth to be included in the study were presence of deep caries, presence of at least two-thirds of the root length radiographically and being restorable. Exclusion Criteria: - The exclusion criteria were the presence of any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL) space, furcal or periapical radiolucency and teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure. Teeth without permanent successor were not also included in the study. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Istanbul University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Total success rate | Number of molars with both clinically and radiographically successful | 6 months after pulpotomy treatment | |
| Primary | Total success rate | Number of molars with both clinically and radiographically successful | 12 months after pulpotomy treatment | |
| Primary | Total success rate | Number of molars with both clinically and radiographically successful | 24 months after pulpotomy treatment |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01733420 -
Biodentine Versus White MTA Pulpotomy
|
Phase 3 |